A61K 31/655
Azo , diazo , azoxy , azido or diazoamino compounds
Official title: Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
A61K31/655 (Azo , diazo , azoxy , azido or diazoamino compounds) appears on 526 US grants and 905 published applications in this corpus.
Search patents in A61K- Granted patents
- 526
- Published applications
- 905
- Assignees
- 521
- Inventors
- 1,790
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 16 | 0 |
| 1998 | 8 | 0 |
| 1999 | 12 | 0 |
| 2000 | 6 | 0 |
| 2001 | 10 | 1 |
| 2002 | 6 | 13 |
| 2003 | 8 | 31 |
| 2004 | 10 | 23 |
| 2005 | 6 | 40 |
| 2006 | 7 | 30 |
| 2007 | 11 | 45 |
| 2008 | 12 | 25 |
| 2009 | 13 | 25 |
| 2010 | 17 | 39 |
| 2011 | 24 | 35 |
| 2012 | 17 | 40 |
| 2013 | 21 | 44 |
| 2014 | 21 | 51 |
| 2015 | 38 | 43 |
| 2016 | 23 | 59 |
| 2017 | 26 | 39 |
| 2018 | 22 | 36 |
| 2019 | 23 | 40 |
| 2020 | 16 | 28 |
| 2021 | 18 | 52 |
| 2022 | 13 | 56 |
| 2023 | 22 | 36 |
| 2024 | 21 | 32 |
| 2025 | 24 | 27 |
| 2026 | 13 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions for the treatment of rheumatoid arthritis and methods of using same29 Sep 2026US 12,747,487 B2Regeneron Pharmaceuticals, Inc.
- Calixarene compounds and uses thereof25 Aug 2026US 12,714,682 B2Universität Wien
- Nitric oxide therapies23 Jun 2026US 12,661,477 B2VERO Biotech Inc.
- Urea, amide, and substituted heteroaryl compounds for CBL-B inhibition16 Jun 2026US 12,653,809 B2Nurix Therapeutics, Inc.
- Methods of monitoring inflammatory bowel diseases9 Jun 2026US 12,650,434 B2Icahn School of Medicine at Mount Sinai
- Methods and compositions for initiating, regulating, and modulating weight loss and therapeutic applications thereof3 Sep 2026US 2026/0256749 A1Kojin Therapeutics, Inc.
- Multi-component pharmaceutical compositions and kits containing nitric oxide releasing compounds and methods of using same27 Aug 2026US 2026/0248819 A1KNOW Bio, LLC
- Treatment of cancer with immune stimulators6 Aug 2026US 2026/0224667 A1Sciclone Pharmaceuticals International (Sg) Pte. Ltd.
- Compositions and articles comprising (nano)diamond particles2 Jul 2026US 2026/0183419 A1Debina Diagnostics, Inc.
- Translocator protein ligands and inflammatory diseases25 Jun 2026US 2026/0174761 A1Technion Research & Development Foundation Limited
Most cited
By later US patents
- Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders196US 5,405,919 AThe United States of America as represented by the Secretary of Health and Human Services · 1995
- Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same185US 5,525,357 AThe United States of America as represented by the Department of Health and Human Services · 1996
- Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents109US 4,954,526 AThe United States of America as represented by the Department of Health and Human Services · 1990
- Compositions and methods for treating bone deficit conditions109US 5,919,808 AOsteoScreen, Inc. · 1999
- Compositions and methods for treating bone deficit conditions106US 5,965,573 AOsteoScreen, Inc. · 1999